XDH and chronic kidney disease: Focusing on the effect of allopurinol treatment on vascular function, Sun et al. found no association between serum XO activity or endothelial XO expression and biomarkers of vascular inflammation or OS in patients with stage 3 CKD and asymptomatic hyperuricemia [80].